During the past decade, HNO Gemeinschaftspraxis conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HNO Gemeinschaftspraxis" are "Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials), "House Dust Mite Allergy" (1 trials) and "Subjective Tinnitus" (1 trials). Many other conditions were trialed in "HNO Gemeinschaftspraxis" in a lesser frequency.

Most popular intervention types in "HNO Gemeinschaftspraxis" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AM-101 0.81 mg/mL" (1 trials), "OTO-313" (1 trials), "PURETHAL Mites 100,000 AU/ml" (1 trials) and "PURETHAL Mites 20,000 AU/ml" (1 trials). Other intervention names were less common.

The vast majority of trials in "HNO Gemeinschaftspraxis" are 5 trials for "All" genders.

Currently, there are NaN active trials in "HNO Gemeinschaftspraxis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in HNO Gemeinschaftspraxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HNO Gemeinschaftspraxis, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".